Last Updated: June 9, 2026

CLINICAL TRIALS PROFILE FOR DURYSTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for durysta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT07217678 ↗ Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use NOT_YET_RECRUITING AbbVie PHASE4 2026-01-31 The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular surface inflammation, indicated by levels of caspase-1, an inflammatory biomarker.
NCT07217678 ↗ Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use NOT_YET_RECRUITING University of Miami PHASE4 2026-01-31 The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular surface inflammation, indicated by levels of caspase-1, an inflammatory biomarker.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for durysta

Condition Name

Condition Name for durysta
Intervention Trials
Glaucoma 1
Glaucoma Suspect 1
Ocular Hypertension 1
Open-Angle Glaucoma 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for durysta
Intervention Trials
Ocular Hypertension 1
Glaucoma, Open-Angle 1
Glaucoma 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for durysta

Trials by Country

Trials by Country for durysta
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for durysta
Location Trials
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for durysta

Clinical Trial Phase

Clinical Trial Phase for durysta
Clinical Trial Phase Trials
PHASE4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for durysta
Clinical Trial Phase Trials
NOT_YET_RECRUITING 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for durysta

Sponsor Name

Sponsor Name for durysta
Sponsor Trials
AbbVie 1
University of Miami 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for durysta
Sponsor Trials
INDUSTRY 1
OTHER 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.